Sloan Sheldon
Chief Medical Officer
Sloan Sheldon has filed 4 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 3, 2026.
On the most recent filing, Sloan Sheldon is listed as Chief Medical Officer at Spyre Therapeutics, Inc. Inside the rolling window, Sloan Sheldon reported no open-market purchases and 4 open-market sales totaling $7.4M in SYRE. The largest disclosed transaction in the window is a sale of 78,333 SYRE shares on May 1, 2026, worth $5.6M.
Companies traded
Other insiders at SYRE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sloan Sheldon made?
Sloan Sheldon has filed 4 SEC Form 4 filings (15 transaction rows) across 1 company since 2026.
Which companies does Sloan Sheldon trade?
Sloan Sheldon has filed SEC Form 4 disclosures for 1 company, including SYRE.
When was Sloan Sheldon's most recent SEC Form 4 filing?
Sloan Sheldon's most recent SEC Form 4 filing on Tracefour is dated Jul 3, 2026.
What is Sloan Sheldon's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sloan Sheldon is listed as Chief Medical Officer.
What is Sloan Sheldon's total buy and sell value in the current window?
Inside the rolling retention window, Sloan Sheldon bought $0 and sold $7.4M based on SEC Form 4 filings.
What was Sloan Sheldon's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 78,333 SYRE shares on 2026-05-01, worth $5.6M, per SEC Form 4 filings.